About US
Contact us
-
CFDA Minister Zhang Yong meets Minister of Health, Welfare and Sports of the Netherlands and Ambassador of the Netherlands to ChinaOn September 10, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Edith Schippers, Minister of Health, Welfare and Sports of the Netherland2013/9/12
-
FDA ratchets up requirements on long-acting, extended-release opioidsLabeling must indicate they are for severe pain only; drugmakers must do studies on abuse potential The FDA, under pressure to help curb abuse ofopioid painkillers, has taken yet another step to damp2013/9/11
-
Lilly's warehouse burglar targeted GlaxoSmithKline, tooA burglar who pulled off a bold warehouse theft at an Eli Lilly ($LLY) facility has now admitted that he made off with millions in GlaxoSmithKline ($GSK) products in a previous heist.2013/9/11
-
Bayer's Xarelto faces stepped-up reports of side effects, deathsThe number of side-effect reports onBayer's anticoagulant drugXareltoappears to be increasing, and some doctors are growing wary of using the drug as a standard first-line treatment,the German newspap2013/9/10
-
GSK unloading drinks brands to Japan's Suntory for $2.1BGlaxoSmithKline ($GSK) is slimming down again, this time with a long-anticipated deal to sell off two of its drinks brands. What was not anticipated was the price--£1.35 billion, or $2.11 billio2013/9/10
-
Celgene's Abraxane approved for first-line treatment of pancreatic cancerThe FDA today approved Celgene'sAbraxaneforpancreatic cancer, an approval that provides some hope for extending the lives of patients with the aggressive cancer. It should also significantly extend th2013/9/9
-
Mallinckrodt tamper-resistant drug performs well for bunion patientsMallinckrodt ($MNK) has released good-news data from a Phase III study of an experimental pain drug for use by patients after bunion surgery. In June, the Dublin, Ireland-based drugmaker submitted a n2013/9/9
-
Merck poised for expansion of Zostavax shingles vax as demand growsAnalysts predicted Merck's ($MRK)shinglesvaccineZostavaxwould be a blockbuster when it was first released in 2006. But Merck quickly ran into manufacturing and supply issues, putting a damper on sales2013/9/6
-
Sanofi bets on safer aspirin combos with $35M Pozen dealSanofi ($SNY) is handing over a $15 million upfront payment along with promises of $20 million in precommercialization milestones to partner with Chapel Hill, NC-based Pozen ($POZN) on a pair of new-a2013/9/6
-
GlaxoSmithKline near $1.6B drinks-brands sale to Japan's SuntoryGlaxoSmithKline ($GSK) may be on the verge of bidding goodbye to two of its drink brands.Japan's Suntory Beverage & Food is in advanced talks to buy Lucozade and Ribena, the brands GSK put up for2013/9/6